Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease

Clinica Chimica Acta

Volumn 378, Issue 1-2, 2007, Pages 136-141

  Fong, Chin Shih ^a   Wu, Ruey Meei ^b   Shieh, Jia Ching ^c   Chao, Ya Ting ^d   Fu, Yi Ping ^e   Kuao, Chiz Liang ^c   Cheng, Chun Wen ^c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic polymorphism; MnSOD; NQO1; Parkinson's disease; Pesticide

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; OXIDOREDUCTASE; PESTICIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; UNCLASSIFIED DRUG;

AGED; ALLELE; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC AND RACIAL GROUPS; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POPULATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SEX; STATISTICAL SIGNIFICANCE; TAIWAN;

AGED; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); PARKINSON DISEASE; PESTICIDES; POLYMORPHISM, GENETIC; REACTIVE OXYGEN SPECIES; RISK; SUPEROXIDE DISMUTASE;

EID: 33846894758     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.006     Document Type: Article

References (38)

1. Scherman D., Desnos C., Darchen F., Pollak P., Javoy-Agid F., and Agid Y. Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 26 (1989) 551-557
2. Jellinger KA. Recent developments in the pathology of Parkinson's disease. J Neural Transm Suppl 62 (2002) 347-376
3. Gasser T. Autosomal-dominantly inherited forms of Parkinson's disease. J Neural Transm Suppl 58 (2000) 31-40
4. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
5. Satoh J., and Kuroda Y. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. J Neurol Sci 189 (2001) 113-117
6. Forsberg L., de Faire U., and Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389 (2001) 84-93
7. Priyadarshi A., Khuder S.A., Schaub E.A., and Priyadarshi S.S. Environmental risk factors and Parkinson's disease: a metaanalysis. Environ Res 86 (2001) 122-127
8. Gorell J.M., Peterson E.L., Rybicki B.A., and Johnson C.C. Multiple risk factors for Parkinson's disease. J Neurol Sci 217 (2004) 169-174
9. Langston J.W., and Ballard Jr. P.A. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 309 (1983) 310
10. Mizuno Y., Sone N., Suzuki K., and Saitoh T. Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain. J Neurol Sci 86 (1988) 97-110
11. Speciale S.G. MPTP: insights into parkinsonian neurodegeneration. Neurotoxicol Teratol 24 (2002) 607-620
12. Gille G., Hung S.T., Reichmann H., and Rausch W.D. Oxidative stress to dopaminergic neurons as models of Parkinson's disease. Ann N Y Acad Sci 1018 (2004) 533-540
13. Langston J.W., and Ballard P. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci 11 (1984) 160-165
14. Gonzalez-Polo R.A., Soler G., Rodriguezmartin A., Moran J.M., and Fuentes J.M. Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants. Cell Biol Int 28 (2004) 373-380
15. Yang W., and Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 68 (2005) 1939-1961
16. Mollace V., Iannone M., Muscoli C., et al. The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non-peptidyl superoxide dismutase mimetic. Neurosci Lett 335 (2003) 163-166
17. Grasbon-Frodl E.M., Kosel S., Riess O., Muller U., Mehraein P., and Graeber M.B. Analysis of mitochondrial targeting sequence and coding region polymorphisms of the manganese superoxide dismutase gene in German Parkinson disease patients. Biochem Biophys Res Commun 255 (1999) 749-752
18. Cheng T.C., Chen S.T., Huang C.S., et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113 (2005) 345-353
19. Hung R.J., Boffetta P., Brennan P., et al. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 25 (2004) 973-978
20. Cai Q., Shu X.O., Wen W., et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai beast cancer study. Breast Cancer Res 6 (2004) R647-R655
21. Shimoda-Matsubayashi S., Hattori T., Matsumine H., et al. MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology 49 (1997) 1257-1262
22. Chen S., Wu K., and Knox R. Structure-function studies of DT-diaphorase (NQO1) and NHR: quinine oxidoreductase (NQO2). Free Radic Biol Med 29 (2000) 276-284
23. Siegel D., McGuinness S.M., Winski S.L., and Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1. Pharmacogenetics 9 (1999) 113-121
24. Ross D., Kepa J.K., Winski S.L., Beall H.D., Anwar A., and Siegel D. NAD(P)H:quinoneoxidoreductase I (NQOI):chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem Bio Interact 129 (2000) 77-97
25. Farin F.M., Hitosis Y., Hallagan S.E., et al. Genetic polymorphisms of superoxide dismutase in Parkinson's disease. Mov Disord 16 (2001) 705-707
26. Harada S., Fujii C., Hayashi A., and Ohkoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II enzymes: glutathione S-transferases and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288 (2001) 887-892
27. Kleinbaum D.G., Kupper L.L., and Muller K.E. Applied regression analysis and other multivariable methods (1998), PWS-KENT Publishing Company, Boston
28. Hertzman C., Wiens M., Bowering D., Snow B., and Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17 (1990) 349-355
29. Liou H.H., Tsai M.C., Chen C.J., et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48 (1997) 1583-1588
30. Li A.A., Mink P.J., McIntosh L.J., Teta M.J., and Finley B. Evaluation of epidemiologic and animal data associating pesticides with Parkinson's disease. J Occup Environ Med 47 (2005) 1059-1087
31. Bus J.S., and Gibson J.E. Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 55 (1984) 37-46
32. Shao M., Liu Z., Tao E., and Chen B. Polymorphism of MAO-B gene and NAD(P)H: quinone oxidoreductase gene in Parkinson's disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18 (2001) 122-124
33. Jiang X.H., Yang H., Yang J.F., Wang H.T., Xu Q.Y., and Chen B. Study on the relationship between polymorphism of human NAD(P)H: quinone oxidoreductase and Parkinson's disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21 (2004) 120-123
34. Okada S., Farin F.M., Stapleton P., et al. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes. Neurosci Lett 375 (2005) 178-180
35. Hong Y.C., Lee K.H., Yi C.H., Ha E.H., and Christiani D.C. Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett 129 (2002) 255-262
36. Menegon A., Board P.G., Blackburn A.C., Mellick G.D., and Le Couteur D.G. Parkinson's disease, pesticide, and glutathione transferase polymorphisms. Lancet 352 (1998) 1344-1346
37. Farin F.M., Janssen P., Quigley S., et al. Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogenetics 11 (2001) 703-708
38. Wu R.M., Cheng C.W., Chen K.H., et al. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 56 (2001) 375-382